Publications by authors named "Alan P Carpenter"

Claim this Profile
N
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
Brittany N Dugger, Christopher M Clark, Geidy Serrano, Monica Mariner, Barry J Bedell, Alan P Carpenter

J Neuropathol Exp Neurol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation dosimetry of florbetapir F 18.
Abhinay D Joshi, Michael J Pontecorvo, Lee Adler, Michael G Stabin, Daniel M Skovronsky, Alan P Carpenter

EJNMMI Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.
Keith A Johnson, Reisa A Sperling, Christopher M Gidicsin, Jeremy S Carmasin, Jacqueline E Maye, Alan P Carpenter

Alzheimers Dement· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
Adam S Fleisher, Kewei Chen, Xiaofen Liu, Napatkamon Ayutyanont, Auttawut Roontiva, Alan P Carpenter

Neurobiol Aging· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, Alan P Carpenter

Lancet Neurol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Abhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, Alan P Carpenter, Danna L Jennings

J Nucl Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoride-18 radiolabeling of peptides bearing an aminooxy functional group to a prosthetic ligand via an oxime bond.
Patrick Carberry, Alan P Carpenter, Hank F Kung

Bioorg Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
John Lister-James, Michael J Pontecorvo, Chris Clark, Abhinay D Joshi, Mark A Mintun, Alan P Carpenter

Semin Nucl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of florbetapir-PET for imaging beta-amyloid pathology.
Christopher M Clark, Julie A Schneider, Barry J Bedell, Thomas G Beach, Warren B Bilker, Alan P Carpenter

JAMA· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons.
Franz F Hefti, Hank F Kung, Michael R Kilbourn, Alan P Carpenter, Christopher M Clark

PET Clin· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis